Dutasteride vs Finasteride: What’s the Difference for Hair Loss?

Both medicines reduce DHT (a key driver of male pattern hair loss). Here’s how they compare on strength, evidence, side effects, and safety — in simple terms.

Quick summary (for skimmers)

• • Finasteride is a type II DHT‑blocking medicine and is commonly used for male pattern hair loss.
  • Dutasteride blocks DHT more broadly (type I and II) and reviews report it can be more effective, but it’s typically used under closer clinician decision‑making depending on the country and licensing.
  • Side effects can happen with both, most commonly sexual side effects and breast tenderness/enlargement; many reports describe them as uncommon and often reversible, but experiences vary.

1) What do finasteride and dutasteride actually do?

Male pattern hair loss is strongly linked to DHT, a hormone that can shrink hair follicles over time in genetically susceptible men.

Both finasteride and dutasteride are 5‑alpha reductase inhibitors, meaning they reduce the conversion of testosterone into DHT.

The main difference: finasteride targets type II, while dutasteride targets type I and type II, which is one reason dutasteride is often described as the stronger DHT‑reducing option in reviews.

2) Which one works better for hair loss?

Both medicines have evidence supporting hair improvement in male pattern hair loss. A JAAD meta‑analysis found finasteride (and minoxidil) were effective compared with placebo in men with androgenetic alopecia.

For dutasteride, an updated review notes that oral dutasteride has better efficacy than finasteride with similar tolerability overall, while still calling out that sexual and psychiatric risks should be considered.

There’s also more recent trial evidence for a low dose: a Phase III randomized trial (men with androgenetic alopecia) reported 0.2% dutasteride improved hair count compared with placebo at 24 weeks, with a favorable safety profile in that study. [

Plain English: finasteride is a proven standard option; dutasteride may offer stronger results for some men, but choice depends on suitability and risk tolerance discussed with a clinician.

3) Side effects: what’s common and what to watch for

For dutasteride, official prescribing information lists the most common adverse reactions (≥1% and more than placebo) as:

• • erectile/sexual function problems (impotence)
  • decreased libido
  • ejaculation disorders
  • breast disorders

For finasteride, patient information sources and leaflets describe that side effects are uncommon, but can include reduced sex drive and reduced ability to get an erection.

A review focused on reproductive effects reports that sexual adverse effects are commonly described as uncommon and often resolve, but also notes there is no complete consensus on how often they occur or how long they last in every case.

Dashboard‑style patient wording tip: keep it simple — “If side effects persist or worry you, pause and contact your clinician.”

4) Safety rules that matter (especially for dutasteride)

These are important and easy to miss:

Pregnancy handling warning

Women who are pregnant or may become pregnant should not handle dutasteride capsules, due to potential risk to a male fetus.

Blood donation restriction

Men taking dutasteride should not donate blood until 6 months after the last dose.

PSA (prostate test) note

Dutasteride reduces PSA by about 50%, so any confirmed rise from the lowest PSA value should be evaluated. Patients should tell their GP/clinician they are taking it before PSA testing.

5) So… which one should someone choose?

This isn’t something a blog should “prescribe,” but here’s a practical way to frame it:

• • Finasteride is often the starting point for many men because it’s widely recognised for male pattern hair loss and has clear patient guidance for that use.
  • Dutasteride may be considered when a clinician believes stronger DHT reduction is appropriate, or when results with other options are not sufficient — but the safety notes (pregnancy handling, PSA effect, blood donation) should be clearly explained.

6) Key takeaways

• • Both treatments work by lowering DHT, which is central to male pattern hair loss.
  • Dutasteride is described in reviews as more effective than finasteride for some men, with similar overall tolerability — but potential risks still need consideration.

Safety rules around dutasteride (pregnancy handling, PSA changes, blood donation) are non‑negotiable and should be clearly shown in patient information.